SomnoMed target price raised to A$0.76 by Morgans
Morgans raised its SomnoMed target price by 1.3% to A$0.76 per share.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Morgans raised its SomnoMed target price by 1.3% to A$0.76 per share.